Progressive Pulmonary Fibrosis Clinical Trials

24 clinical trials for Progressive Pulmonary Fibrosis across international registries, including 13 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Emotional and Social Experiences of Antifibrotic (AF) Therapy Among Idiopathic Pulmonary Fibrosis (IPF)/Progressive Pulmonary Fibrosis (PPF) Patients: A Real-World Study — RECRUITING
• An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL) — RECRUITING · PHASE2
• A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast — RECRUITING · PHASE3
• A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants with Progressive Pulmonary Fibrosis — RECRUITING · PHASE3
• Extension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung Disease — RECRUITING · PHASE3
• Finger Versus Earlobe Pulse Oximetry During the 6-Minute Walk Test in Interstitial Lung Disease — RECRUITING
• Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF) — RECRUITING · PHASE3
• A Prospective, Multi-Center Registry Study of Progressive Pulmonary Fibrosis (PPF) in China (PROFINA) — RECRUITING
• Optimizing the Follow-Up Journey in Interstitial Lung Disease: The OPTIMIZE-ILD-2 Trial — RECRUITING · NA
• Study on the Efficacy of Quercetin Intake in Patients With Fibrotic Interstitial Lung Diseases. — RECRUITING · NA
• SUPPORT-T in Patients With Progressive Pulmonary Fibrosis and Their Caregivers — RECRUITING · NA
• A Pilot Study to Assess Body Mass Composition Measurement Using BIA and Muscle Ultrasound in IPF and PPF Patients on Anti-fibrotic Medications — RECRUITING
• PRospective phenotypIng and Multi-omic Endotyping of Progressive Pulmonary Fibrosis — RECRUITING
• Antifibrotic Therapy Decision-Making in Pulmonary Fibrosis — NOT_YET_RECRUITING
• A Randomized, Double-blind, Placebo-controlled, Multinational, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects with Progressive Pulmonary Fibrosis (TETON-PPF) — TERMINATED · PHASE3
• A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis — ACTIVE_NOT_RECRUITING · PHASE2
• A Randomized, Double-Blind, Placebo-Controlled, Phase 2b Study Evaluating the Safety and Efficacy of Pirfenidone Solution for Inhalation (AP01) in Subjects with Progressive Pulmonary Fibrosis (PPF) — TERMINATED · PHASE2
• Xenon MRI and Progressive ILD — ACTIVE_NOT_RECRUITING · PHASE2
• Hereditary Influences on Pulmonary Fibrosis Trajectories — ACTIVE_NOT_RECRUITING
• Occupational and Environmental Exposures Analysis in Interstitial Lung Diseases. — ACTIVE_NOT_RECRUITING
• A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis — ACTIVE_NOT_RECRUITING · PHASE3
• Evaluating the Efficacy and Safety of of HSK44459 in People With Progressive Pulmonary Fibrosis — NOT_YET_RECRUITING · PHASE3
• A Study to Test Whether BI 1839100 Improves Cough in People With Idiopathic Pulmonary Fibrosis or Progressive Pulmonary Fibrosis — TERMINATED · PHASE2
• PET/CT imaging with FAPI as a biomarker for the distinction between predominant active fibrotic and inflammatory phenotypes in patients with progressive pulmonary fibrosis: The FIBRO-PET study. — OTHER · PHASE2

Refine this search